Corden Pharma

Plankstadt, Germany Founded: 2006 • Age: 20 yrs Acquired By International Chemical Investors
CDMO offering its services for small molecules, peptides, lipids and carbohydrates
Request Access

About Corden Pharma

Corden Pharma is a company based in Plankstadt (Germany) founded in 2006 was acquired by International Chemical Investors in February 2013.. Corden Pharma has completed 1 acquisition, including Ancora Pharmaceuticals. Corden Pharma offers products and services including APIs, Drug Products, and Lipid Excipients. Corden Pharma operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.

  • Headquarter Plankstadt, Germany
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Corden Pharma

Corden Pharma offers a comprehensive portfolio of products and services, including APIs, Drug Products, and Lipid Excipients. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Development and manufacturing of drug substances for pharmaceuticals

Production of sterile and non-sterile forms for drug delivery

Creation of lipid-based products for pharmaceutical formulations

People of Corden Pharma
Headcount 1000-5000
Employee Profiles 153
Employee Profiles
People
Tyler M.
Plant Manager
People
Anna Haviland
Senior Chemical Process Engineer
People
Phillip Chalabi
Vice President, Head Of North America Sales
People
Brittany Slupe
Senior Ms&t Engineer

Unlock access to complete

Funding Insights of Corden Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Corden Pharma

Corden Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include International Chemical Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
A privately owned industrial group focused on chemical investments.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Corden Pharma

Corden Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Ancora Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Vaccines for hospital-acquired infections are developed in preclinical stages.
2002
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Corden Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Corden Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Corden Pharma

Corden Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Integrated CDMO services for biopharma R&D and manufacturing are offered.
domain founded_year HQ Location
APIs and peptides are developed and manufactured by Asymchem.
domain founded_year HQ Location
Contract manufacturing services for small molecules and peptides are provided.
domain founded_year HQ Location
Generic biocatalytic solutions are provided for pharmaceutical applications.
domain founded_year HQ Location
Contract research and development services for small molecules are offered.
domain founded_year HQ Location
APIs manufacturing and formulation services are provided in therapeutic segments.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Corden Pharma

Frequently Asked Questions about Corden Pharma

When was Corden Pharma founded?

Corden Pharma was founded in 2006.

Where is Corden Pharma located?

Corden Pharma is headquartered in Plankstadt, Germany. It is registered at Plankstadt, Baden-wurttemberg, Germany.

What does Corden Pharma do?

CordenPharma is a full-service partner in the Contract Development and Manufacturing (CDMO) of APIs, Drug Products and associated Packaging, Logistics, and Clinical Supply Services. Through their network of fully-inspected cGMP facilities across Europe and the US which are organised under six technology platforms namely, Antibiotics, Highly Potent Oncology Products, Small Molecules, PeptidesLipids Carbohydrates, Injectables, Fermentation Enzymes they offer product development and manufacturing services. The company has facilities in Italy, US, Germany, France, Belgium and Switzerland. CordenPharma claims that it can translate complex ideas at any stage of development into high-value products. CordenPharma specialises in the development of oncology drugs(Sterile and Oral dosage forms, including HPAPIs) and fermentation based small molecules.

Who are the top competitors of Corden Pharma?

Corden Pharma's top competitors include Concord Biotech, Almac Group and Indoco Remedies.

What products or services does Corden Pharma offer?

Corden Pharma offers APIs, Drug Products, and Lipid Excipients.

How many acquisitions has Corden Pharma made?

Corden Pharma has made 1 acquisition, including Ancora Pharmaceuticals.

Who are Corden Pharma's investors?

Corden Pharma has 1 investor. Key investors include International Chemical Investors.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available